详情页 - 首都医科大学附属北京同仁医院知识库

当前位置：首页 > 详情页

Author Correction: Targeting Hsp90 with FS-108 circumvents gefitinib resistance in EGFR mutant non-small cell lung cancer cells.

文献详情

资源类型：

Pubmed体系：

收录情况： ◇ 统计源期刊 ◇ CSCD-C ◇ 卓越：重点期刊

作者：

机构： [1]Department of New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China. [2]Division of Anti-tumor Pharmacology, Synthetic Organic and Medicinal Chemistry Laboratory, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. [3]Synthetic Organic and Medicinal Chemistry Laboratory, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. [4]Division of Anti-tumor Pharmacology, Synthetic Organic and Medicinal Chemistry Laboratory, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. mygeng@simm.ac.cn. [5]Department of Thoracic Surgery, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200336, China. zhengmin8010@126.com. [6]Division of Anti-tumor Pharmacology, Synthetic Organic and Medicinal Chemistry Laboratory, State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, 201203, China. jding@simm.ac.cn.

出处：

DOI：

ISSN：

摘要：

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

语种：

PubmedID：

中科院(CAS)分区：

出版当年[2019]版：

大类 | 2 区医学

小类 | 2 区化学综合 2 区药学

最新[2023]版：

大类 | 1 区

医学

小类 | 1 区药学 2 区化学：综合

第一作者：

第一作者机构： [1]Department of New Drug Screening Center, China Pharmaceutical University, Nanjing, 210009, China.

推荐引用方式(GB/T 7714)：

APA：

MLA：